Primary liver cancer—including hepatocellular carcinoma (HCC) and intrahepatic
cholangiocarcinoma (ICC)—incidence is increasing and is an important source of cancer …

Liver transplantation (LT) offers excellent long-term outcome for certain patients with
hepatocellular carcinoma (HCC), with a push to not simply rely on tumor size and number …

This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …

Background Intrahepatic recurrence is a significant problem for patients who have
undergone a hepatic resection for hepatocellular carcinoma (HCC). The objective of the …

Objective: This study aims to validate a previously reported recurrence clinical risk score
(CRS). Summary of Background Data: Salvage transplantation after hepatocellular …

Background and purpose The clinical role of postoperative adjuvant therapy in
hepatocellular carcinoma (HCC) is still unclear. The purpose of our study was to explore the …

Background The effects of direct-acting antivirals (DAAs) on survival and recurrence rates
after curative hepatocellular carcinoma (HCC) treatment in patients with hepatitis C virus …

The Coronavirus disease 2019 (COVID-19) pandemic is expected to have a long-lasting
impact on the approach to care for patients at risk for and with hepatocellular carcinoma …

Background The ability to predict the incidence, timing, and site of recurrence can be
beneficial to select surgical candidates and inform appropriate postoperative surveillance …

Abstract Purpose of Review Hepatocellular carcinoma (HCC) is the third leading cause of
cancer-related death in the United States (US). 1 The purpose of this review is to highlight …